| 1 |
35326731 | Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy. | 2022 Mar 20 |
2 |
| 2 |
35523809 | The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy. | 2022 May 6 |
1 |
| 3 |
33986285 | Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's disease. | 2021 May 13 |
1 |
| 4 |
34073458 | Treg-Resistant Cytotoxic CD4+ T Cells Dictate T Helper Cells in Their Vicinity: TH17 Skewing and Modulation of Proliferation. | 2021 May 26 |
2 |
| 5 |
34384744 | Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes. | 2021 Aug |
2 |
| 6 |
34592958 | Impact of immune checkpoint molecules on FoxP3+ Treg cells and related cytokines in patients with acute and chronic brucellosis. | 2021 Sep 30 |
2 |
| 7 |
34691057 | Crosstalk of Microorganisms and Immune Responses in Autoimmune Neuroinflammation: A Focus on Regulatory T Cells. | 2021 |
1 |
| 8 |
32351508 | IL36 Cooperates With Anti-CTLA-4 mAbs to Facilitate Antitumor Immune Responses. | 2020 |
1 |
| 9 |
32621335 | CTLA-4 and HLA-DQ are key molecules in the regulation of mDC-mediated cellular immunity by Tregs in severe aplastic anemia. | 2020 Oct |
1 |
| 10 |
32840510 | Hybrid spherical nucleotide nanoparticles can enhance the synergistic anti-tumor effect of CTLA-4 and PD-1 blockades. | 2020 Sep 7 |
1 |
| 11 |
33490159 | Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis. | 2020 Dec |
1 |
| 12 |
29367462 | High self-reactivity drives T-bet and potentiates Treg function in tissue-specific autoimmunity. | 2018 Jan 25 |
1 |
| 13 |
30415745 | Immunomodulatory effects of human amniotic epithelial cells on naive CD4+ T cells from women with unexplained recurrent spontaneous abortion. | 2018 Nov |
1 |